)
Visual24 Oct 2025
The rise of Alphabet
Mainz Biomed (MYNZ) investor relations material
Mainz Biomed H2 2024 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.H2 2024 earnings summary1 Apr, 2025
Executive summary
Focused on at-home molecular diagnostics for early cancer detection, especially colorectal cancer, with flagship product ColoAlertⓇ and next-gen pipeline targeting advanced adenomas and pancreatic cancer.
Disruptive decentralized business model enables broad lab access and international expansion.
Strategic partnerships with Thermo Fisher Scientific and Quest Diagnostics to advance next-gen colorectal cancer screening and U.S. commercialization.
Lab network revenue grew 33% year-over-year, driven by strong demand for ColoAlertⓇ in Europe.
Early 2025 updates include Nasdaq compliance and first patient enrolled in eAArly DETECT 2 study.
Financial highlights
2024 revenue: $893,991, nearly flat compared to $895,479 in 2023.
Gross profit: $574,883 (64% margin) in 2024, up from $509,659 (57%) in 2023.
Net loss: $(21,650,663) in 2024, improved from $(26,295,727) in 2023.
Operating expenses: $19.3M in 2024, down from $27.2M in 2023.
Cash and equivalents at year-end 2024: $6.2M, down from $7.1M in 2023; total debt: $6,046,543.
Outlook and guidance
Targeting U.S. market entry and FDA pivotal study with Quest Diagnostics as lab partner.
Advancing next-gen mRNA-based CRC and pancreatic cancer screening tests, with large-scale clinical trials planned.
Focus for 2025 is on expanding ColoAlertⓇ in Europe, developing next-gen CRC screening, and advancing eAArly DETECT 2 study.
Top-line results from eAArly DETECT 2 expected by end of 2025.
Strategic cost management and targeted investments to continue.
Assess ColoAlert's European market growth drivers.
Explain the strategic rationale for cost reductions.
Outline the next steps for PancAlert development.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Mainz Biomed earnings date
H1 20253 Nov, 2025
Next Mainz Biomed earnings date
H1 20253 Nov, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Mainz Biomed NV is a Germany-based molecular genetics diagnostic company focused on early detection of cancer. The company develops and commercializes in-vitro diagnostic tests, including non-invasive screening tools for colorectal cancer and other conditions. It operates in European and global markets with a focus on regulated clinical validation. The company is headquartered in Mainz, Germany, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage